What is your estimation of the upfront for Amiket?
My only hold here is that if Pfizer is the partner, then they will be punished with an extra high upfront (60-80 MUSD) and lots of time regulations up to the market intro to secure momentum. They do hold the current market leader. Of course they want to take control the new challenger.
But, also, Amiket is a superb combo given the absence of side effects. Having Amiket in combo with the existing competitors Pfizer makes a smart deal.